Ascendo Biotechnology
PrivateLast Round
Series A
Apr 30, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ascendo Biotechnology operates in Healthcare & Life Sciences and is based in Taipei City. Its latest recorded funding round was a Series A round in April 2026.
Ascendo Biotechnology is a clinical-stage biopharmaceutical company that develops novel cancer immunotherapies and treatments for autoimmune diseases by targeting innate immune checkpoints.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ascendo Biotechnology Comparables
Compare Ascendo Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biond Biologics | 78% | |
| Pheast Therapeutics | 77% | |
| LTZ Therapeutics | 77% |
For institutional investors. Book with your work email.
Ascendo Biotechnology Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Ascendo Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series A |
| Yuanta Venture Capital | Series A |
| Chang Hwa Bank Venture Capital Co., Ltd. | Series A |
| Beiley Biofund | Series A |
| Industrial Technology Investment Corporation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 203% MoM, reaching 467.
- May 18, 2026
Monthly visitors grew 459% MoM, reaching 665.
For institutional investors. Book with your work email.
Ascendo Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ascendo Biotechnology's valuation, stock price, and market status.
Is Ascendo Biotechnology a public or private company?
Ascendo Biotechnology is a private company.
What is the current stock price of Ascendo Biotechnology?
Ascendo Biotechnology is a private company, so its shares have no public market price. Caplight tracks Ascendo Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ascendo Biotechnology worth (valuation)?
Valuation information for Ascendo Biotechnology is not publicly available.
Can I buy Ascendo Biotechnology stock?
Ascendo Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ascendo Biotechnology's last funding round?
Ascendo Biotechnology's most recent funding round was Series A on April 30, 2026.
Who are the main investors in Ascendo Biotechnology?
Key investors in Ascendo Biotechnology include Taiwania Capital, Yuanta Venture Capital, Chang Hwa Bank Venture Capital Co., Ltd., Beiley Biofund, Industrial Technology Investment Corporation.
Will Ascendo Biotechnology IPO soon?
No public IPO plans have been announced for Ascendo Biotechnology.
How can I track Ascendo Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Ascendo Biotechnology's shares on secondary markets.